Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Insmed (INSM) Shares Issued (2016 - 2026)

Insmed's Shares Issued history spans 15 years, with the latest figure at $30.3 million for Q1 2026.

Quarterly Shares Issued rose 2.05% to $30.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $136.3 million through Mar 2026, down 1.85% year-over-year, with the annual reading at $135.7 million for FY2025, 19.85% up from the prior year.
Shares Issued came in at $30.3 million for Q1 2026, up from -$687.6 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $756.6 million in Q3 2025 to a low of -$687.6 million in Q4 2025.
The 5-year median for Shares Issued is $7.3 million (2023), against an average of $26.5 million.
Year-over-year, Shares Issued skyrocketed 9636.45% in 2024 and then tumbled 5104.11% in 2025.
Insmed's Shares Issued stood at $2.2 million in 2022, then skyrocketed by 5172.27% to $114.5 million in 2023, then tumbled by 88.0% to $13.7 million in 2024, then crashed by 5104.11% to -$687.6 million in 2025, then skyrocketed by 104.41% to $30.3 million in 2026.
Per Business Quant, the three most recent readings for INSM's Shares Issued are $30.3 million (Q1 2026), -$687.6 million (Q4 2025), and $756.6 million (Q3 2025).